In the volatile world of technology stocks, the goal is to stand alone as the market leader, or at the very least excel as a top competitor, with proven products capable of turning a profit while ...

In addition to OEM distribution, the collaboration provides flexibility for potential future expansion, which could include Dyadic supplying market-ready products for distribution or licensing ...

Allied Market Research published a report, titled, "Fibrinogen Concentrate Market by Product Type (Human Fibrinogen Concentrate, Re ...

Read more about Future pandemics may be fought faster with mRNA and advanced vaccine platforms on Devdiscourse ...

These female-led future food startups are using technology to supercharge the women's health and wellness category.

Built in 1902 to house an eccentric inventor’s rare plant collection, preserving this building in San Francisco has been a ...

The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine ...

Produced using Dyadic’s proprietary high-yield fungal microbial expression platforms and Fermbox Bio’s scale-up and biomanufacturing capabilities, Recombinant DNase I (RNase-free) is currently ...

The morning tape is leaning decisively toward defense-linked manufacturers, advanced materials innovators, and capital-raising energy names, as fresh contract wins and strategic investments reinforce ...

Chinese startup Guoke Xinglian has secured ¥100M ($14.6M) in Series A+ funding to scale up its precision-fermented human milk ...

Recombinant humanized collagen has been widely used in the biomedical field. This study focuses on the characterization of a novel recombinant humanized type III collagen cold gel (C3Gel). To verify ...